CoChat

A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Medications indicated for helminthes and other parasitic infections are frequently being used in mass populations in endemic areas. Currently, there is a lack of guidance for clinicians on how to appropriately manage drug interactions when faced with patients requiring short-term anthelmintic therapy with albendazole or mebendazole while concurrently taking other agents. The objective of this review was to systematically summarize and evaluate published literature on the pharmacokinetics of albendazole or mebendazole when taken with other interacting medications. A search of MEDLINE (1946 to October 2014), EMBASE (1974 to October 2014), International Pharmaceutical Abstracts (1970 to October 2014), Google, and Google Scholar was conducted for articles describing the pharmacokinetics of albendazole or mebendazole when given with other medications (and supplemented by a bibliographic review of all relevant articles). Altogether, 17 articles were included in the review. Studies reported data on pharmacokinetic parameters for albendazole or mebendazole when taken with cimetidine, dexamethasone, ritonavir, phenytoin, carbamazepine, phenobarbital, ivermectin, praziquantel, diethylcarbamazine, azithromycin, and levamisole. Cimetidine increased the elimination half-life of albendazole and maximum concentration (Cmax) of mebendazole; dexamethasone increased the area under the plasma concentration-time curve (AUC) of albendazole; levamisole decreased the Cmax of albendazole; anticonvul…

Overview

Integrity signals

Registry

Crossref · 10.1007/s40262-015-0243-9

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 44 references

Research works printed but not linked: 2

  1. Li X-Q, Björkman A, Andersson TB, Gustafsson LL, Masimirembwa CM. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol. 2003;59:429–42. · DOI · Paper page
  2. Lin JH, Lu AYH. Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet. 1998;35:361–90. · DOI · Paper page

Cited by

See all 67

Metadata

Authors
Pawluk, S. A., Roels, C. A., Wilby, K. J., & Ensom, M. H. H.
Affiliations
  • Qatar University (QA)
  • University of British Columbia (CA)
Corresponding author
Pawluk, Shane Ashley
Venue
Clinical Pharmacokinetics
Published
2015-02-18
Volume
54
Issue
4
Pages
371-383
ISSN
  • 0312-5963 (ISSN-L)
  • 1179-1926
OpenAlex
W2050422640
Cited by
59
References
44
Citations by year
2026: 5 · 2025: 2 · 2024: 1 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 9 · 2017: 2 · 2016: 4 · 2015: 1
FWCI
0.97
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Clinical Pharmacokinetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
World Health Organization
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
Keywords
albendazole, mebendazole, anthelmintics, drug-drug interactions, pharmacokinetics, cimetidine, dexamethasone, ritonavir, antiepileptic drugs, phenytoin, phenobarbital, carbamazepine, levamisole, praziquantel, ivermectin, azithromycin, diethylcarbamazine, helminthiasis, parasitic infection
MeSH terms
Adult, Anthelmintics, Child, Child, Preschool, Drug Interactions, Drug Therapy, Combination, Female, Humans, Male, Mebendazole, Albendazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole. https://app.cochat.ai/papers/10.1007/s40262-015-0243-9
The paper
Pawluk, S. A., Roels, C. A., Wilby, K. J., & Ensom, M. H. H. (2015). A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole. Clinical Pharmacokinetics. https://doi.org/10.1007/s40262-015-0243-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.